Kevin Love rose for an insignificant rebound in an insignificant preseason game Friday night at United Center and came down with a fractured left hand that’s expected to sideline him until December.
X-rays taken at the arena showed he broke the fourth metacarpal bone in that hand and the initial estimate is he will miss the next six to eight weeks. Love will see a hand specialist Monday to find out if the injury will require surgery.
Obviously, this isn’t the kind of injury that is going to change the entire landscape of the NBA, but it is a big blow to Love and the T-Wolves, who are hoping to take a step forward this season. From a fantasy perspective, Love may not be drafted in leagues that don’t have an IR slot, but if your league does, it may not be a bad idea to grab him in the final rounds and stash him on your bench until he returns.
Did the Spurs do enough this summer to make another title run? On paper, it sure looks like they did. They added Richard Jefferson to shore up the small forward position, which has declined as Michael Finley and Bruce Bowen have aged. He’s a good defender, especially when he’s not asked to score 20 points a game, and the Spurs won’t put him in that position. The Spurs also signed Antonio McDyess, who is 35 years old, but was quite productive last season as he proved that he still has some gas left in the tank. San Antonio also had the luxury of a top 10 talent (DeJuan Blair) falling into its lap in the second round of the draft due to concerns about his knees, which served him quite well at Pitt. And, of course, the Spurs return their three principals. Tony Parker has developed into one of the best point guards in the game, Manu Ginobili is a clutch closer, and Tim Duncan is still Tim Duncan. Since his game isn’t dependent on athleticism, it continues to age well. The key for the Spurs is staying healthy. If Parker, Ginobili, Duncan and Jefferson are all healthy heading into the playoffs, San Antonio will be a very tough out, even for the Lakers.
The biggest obstacle for the Lakers this season is Ron Artest. This may sound odd, but the franchise is rolling the dice that Ron-Ron can behave for another season. They gave up on the quietly improving Trevor Ariza and made a big move to add the unruly Artest to the roster. This is risky, especially for a team coming off an impressive title run. Why fiddle with your chemistry like that? Well, GM Mitch Kupchak is well aware that the Lakers aren’t getting by on chemistry. They are a group of very talented players, held together loosely by Phil Jackson’s thoughtful approach and Kobe Bryant’s will to win. In other words, chemistry may not matter to the Lakers, because it’s a by-product of winning. (For most teams, it’s the other way around.) There’s no doubt that Artest brings a lot to the table, but he’s the biggest change from last season, so if the Lakers take a step back, he’ll probably get the blame. Meanwhile, it appears that the big lineup question surrounds the Lamar Odom/Andrew Bynum quandary, but the truth is that Bynum’s game has not developed enough to demand that he be on the floor in crunch time. Odom can shoot (albeit, only a little) and is a terrific ball handler/passer, so Jackson knows that he can better space the court than Bynum can. When both Bynum and Pau Gasol are on the floor, the lane gets clogged and Kobe can’t find driving lanes, so look for Odom to get the edge in minutes again this year. But back to Artest — assuming he accepts a reduction in his offensive role, the Lakers are the odds-on favorites to once again represent the West in the Finals.